Ishita Drugs & Industries Ltd.
| BSE: 524400 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE806D01016 |
| BSE 00:00 | 23 Sep | 37.10 |
-1.80 (-4.63%) |
OPEN
37.05 |
HIGH
39.85 |
LOW
37.05 |
| NSE 05:30 | 01 Jan | Ishita Drugs & Industries Ltd |
| OPEN | 37.05 |
| PREVIOUS CLOSE | 38.90 |
| VOLUME | 5861 |
| 52-Week high | 54.00 |
| 52-Week low | 19.00 |
| P/E | 12.66 |
| Mkt Cap.(Rs cr) | 11 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Ishita Drugs & Industries Ltd. (ISHITADRUGS) - Peer Group
| COMPANY | PRICE (In Rs) |
CHG (%) |
MKT CAP (Rs Cr) |
SALES (Rs Cr) |
PROFIT (Rs Cr) |
EPS (Rs) |
P/E (x) |
| Sanjiv.Parant. | 28.30 | -2.75 | 24.06 | 8.08 | 0.63 | 2.96 | 9.56 |
| Parnax Lab | 26.40 | 7.76 | 22.44 | 28.69 | 0.98 | 0.00 | - |
| Ortin Labs. | 27.05 | 0.74 | 21.99 | 13.16 | 0.44 | 4.45 | 6.08 |
| Syschem (India) | 9.24 | -4.15 | 19.90 | 17.41 | -1.49 | 0.00 | - |
| Phaarmasia | 27.00 | 0.75 | 18.44 | 3.89 | 0.04 | 0.44 | 61.36 |
| Pharmaids Pharma | 14.20 | -0.35 | 14.64 | 2.34 | 0.01 | 0.10 | 142.00 |
| Shukra Pharma. | 92.60 | 4.99 | 14.54 | 2.96 | 0.04 | 1.91 | 48.48 |
| Parmax Pharma | 37.85 | -3.57 | 14.16 | 1.73 | -0.44 | 3.52 | 10.75 |
| Roopa Industries | 14.90 | 2.05 | 11.73 | 9.15 | 0.19 | 1.00 | 14.90 |
| Welcure Drugs | 8.38 | 4.88 | 11.32 | 0.02 | -0.02 | 0.02 | 419.00 |
| Ishita Drugs | 37.10 | -4.63 | 11.09 | 2.89 | 0.14 | 2.93 | 12.66 |
| Guj. Terce Labs. | 14.50 | -3.33 | 10.76 | 7.20 | -0.02 | 0.00 | - |
| Parenteral Drugs | 2.75 | -4.84 | 8.20 | 2.93 | -32.04 | 0.00 | - |
| Colinz Labs | 17.50 | -3.31 | 8.00 | 1.85 | 0.08 | 0.52 | 33.65 |
| Veerhealth Care | 9.76 | -4.78 | 6.76 | 2.49 | 0.05 | 0.53 | 18.42 |
| Beryl Drugs | 12.49 | 2.80 | 6.33 | 4.65 | 0.34 | 1.12 | 11.15 |
| Unjha Formul. | 10.00 | 0.00 | 4.48 | 3.89 | 0.50 | 0.75 | 13.33 |
| Hind.Bio Science | 3.52 | 5.07 | 3.61 | 0.19 | -0.08 | 0.00 | - |
Quick Links for Ishita Drugs & Industries:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
